166 related articles for article (PubMed ID: 32435831)
1. Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres.
Ebbers SC; Kunnen B; van Nierop BJ; Bemelmans JLM; Krijger GC; Lam MGEH; Braat AJAT
Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1378-1383. PubMed ID: 32435831
[TBL] [Abstract][Full Text] [Related]
2. Predicting the net administered activity in
Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC
Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Radioembolization with Yttrium-90 Glass Microspheres: Distribution of Residual Activity and Flow Dynamics during Administration.
Drescher R; Seifert P; Gühne F; Kühnel C; Aschenbach R; Freesmeyer M
J Vasc Interv Radiol; 2020 Sep; 31(9):1467-1474. PubMed ID: 32723494
[TBL] [Abstract][Full Text] [Related]
4. Resin 90Y microsphere activity measurements for liver brachytherapy.
Dezarn WA; Kennedy AS
Med Phys; 2007 Jun; 34(6):1896-900. PubMed ID: 17654890
[TBL] [Abstract][Full Text] [Related]
5. Technical Note: Impact of impurities on Yttrium-90 glass microsphere activity quantitation.
Beattie BJ; Kirov AS; Kesner AL
Med Phys; 2024 Mar; 51(3):2306-2310. PubMed ID: 37956259
[TBL] [Abstract][Full Text] [Related]
6. Radioembolization with
Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
[TBL] [Abstract][Full Text] [Related]
7. PET-CT post therapy dosimetry in radioembolization with resin
Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
[TBL] [Abstract][Full Text] [Related]
8. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
10. A Multicenter Study on Observed Discrepancies Between Vendor-Stated and PET-Measured
Gnesin S; Mikell JK; Conti M; Prior JO; Carlier T; Lima TVM; Dewaraja YK
J Nucl Med; 2023 May; 64(5):825-828. PubMed ID: 36418169
[TBL] [Abstract][Full Text] [Related]
11.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Tumor Control in
Dewaraja YK; Devasia T; Kaza RK; Mikell JK; Owen D; Roberson PL; Schipper MJ
J Nucl Med; 2020 Jan; 61(1):104-111. PubMed ID: 31147404
[TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 Activity Quantification in PET/CT-Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro-CT and Autoradiography.
Naydenov N; Teplov A; Zirakchian MZ; Ruan S; Chu BP; Serencsits B; Iraca M; Talarico O; Miller B; Kunin H; Schwartz J; Kesner A; Furenlid LR; Dauer L; Yagi Y; Humm JL; Zanzonico P; Sofocleous CT; Kirov AS
J Vasc Interv Radiol; 2023 Sep; 34(9):1556-1564.e4. PubMed ID: 37201655
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors.
Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC
Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
16. AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization.
Busse NC; Al-Ghazi MSAL; Abi-Jaoudeh N; Alvarez D; Ayan AS; Chen E; Chuong MD; Dezarn WA; Enger SA; Graves SA; Hobbs RF; Jafari ME; Kim SP; Maughan NM; Polemi AM; Stickel JR
J Appl Clin Med Phys; 2024 Feb; 25(2):e14157. PubMed ID: 37820316
[TBL] [Abstract][Full Text] [Related]
17. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
Pasciak AS; Bourgeois AC; Bradley YC
J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases.
Ebbers SC; van Roekel C; Braat MNGJA; Barentsz MW; Lam MGEH; Braat AJAT
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1700-1710. PubMed ID: 34873638
[TBL] [Abstract][Full Text] [Related]
20. [
Vimalnath KV; Rajeswari A; Dixit A; Chakravarty R; Sarma HD; Kulkarni S; Jha A; Puranik A; Rangarajan V; Goswami M; Chakraborty S
Cancer Biother Radiopharm; 2024 Feb; 39(1):82-91. PubMed ID: 38265675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
